Freudenberg Medical, a global company that works with medical device and biopharma industries, has launched a new product called LUBRITEQ. This is a high-performance hydrophilic coating solution, and it comes with a full range of development and manufacturing services. LUBRITEQ is now available worldwide through Freudenberg Medical’s operations.
With the launch of LUBRITEQ, Freudenberg Medical is now the only company that offers hydrophilic coatings, combining advanced surface chemistry with strong in-house medical device design and manufacturing. This brings together different technologies to make the manufacturing process easier and improve product development in terms of reliability and productivity.
Freudenberg Medical has over 25 years of experience in coating science, supported by a history of innovations. They have worked with customers on complex drug-device solutions and surface modification.
The decision to enter the hydrophilic coatings market was based on feedback from customers and industry experts. These discussions highlighted that while coating technologies have improved, there were still gaps in meeting customer needs, especially around flexible support services and dealing with royalties, licenses, and fees.
Executive Statement
According to Michael McGee, CEO of Freudenberg Medical, hydrophilic coatings and device design must work in perfect harmony to deliver optimal performance, yet the industry has traditionally approached them as separate disciplines. As a uniquely integrated technical partner, we enable customers to move faster, with less risk and greater confidence, by combining product design, advanced materials, precision coatings, and application expertise for seamless development, scale-up, and launch.
